Endoskopi af patienter i antitrombotisk og antikoagulerende behandling

Jens Kjeldsen; Torsten Pless; Søren Meisner; Peter Bytzer

Endoskopi af patienter i antitrombotisk og antikoagulerende behandling

Jens Kjeldsen, Torsten Pless, Søren Meisner, Peter Bytzer

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

3 Citationer (Scopus)

Abstract

Drugs that interfere with haemostasis are widely used for thromboembolic diseases and cardiovascular protection. Gastrointestinal bleeding is a well-known complication, and endoscopists are often faced with decisions concerning the safety of endoscopic procedures in these patients. Based on expert opinion and on data from observational studies, we suggest algorithms for the approach to acute and elective procedures based on procedural risk and on risks for thromboembolic episodes.
Udgivelsesdato: 2009-Apr-20

Bidragets oversatte titel	Endoscopy in patients receiving anticoagulation or antiplatelet therapy
Originalsprog	Dansk
Tidsskrift	Ugeskrift for læger
Vol/bind	171
Udgave nummer	17
Sider (fra-til)	1384-6
Antal sider	2
ISSN	0041-5782
Status	Udgivet - 2009

Bibliografisk note

Keywords: Anticoagulants; Blood Loss, Surgical; Emergencies; Endoscopy, Gastrointestinal; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Surgical Procedures, Elective; Thromboembolism; Thrombolytic Therapy

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

@article{f0e07df0333d11df8ed1000ea68e967b,

title = "Endoskopi af patienter i antitrombotisk og antikoagulerende behandling",

abstract = "Drugs that interfere with haemostasis are widely used for thromboembolic diseases and cardiovascular protection. Gastrointestinal bleeding is a well-known complication, and endoscopists are often faced with decisions concerning the safety of endoscopic procedures in these patients. Based on expert opinion and on data from observational studies, we suggest algorithms for the approach to acute and elective procedures based on procedural risk and on risks for thromboembolic episodes. Udgivelsesdato: 2009-Apr-20",

author = "Jens Kjeldsen and Torsten Pless and S{\o}ren Meisner and Peter Bytzer",

note = "Keywords: Anticoagulants; Blood Loss, Surgical; Emergencies; Endoscopy, Gastrointestinal; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Surgical Procedures, Elective; Thromboembolism; Thrombolytic Therapy",

year = "2009",

language = "Dansk",

volume = "171",

pages = "1384--6",

journal = "Ugeskrift for l{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "17",

}

TY - JOUR

T1 - Endoskopi af patienter i antitrombotisk og antikoagulerende behandling

AU - Kjeldsen, Jens

AU - Pless, Torsten

AU - Meisner, Søren

AU - Bytzer, Peter

N1 - Keywords: Anticoagulants; Blood Loss, Surgical; Emergencies; Endoscopy, Gastrointestinal; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Surgical Procedures, Elective; Thromboembolism; Thrombolytic Therapy

PY - 2009

Y1 - 2009

N2 - Drugs that interfere with haemostasis are widely used for thromboembolic diseases and cardiovascular protection. Gastrointestinal bleeding is a well-known complication, and endoscopists are often faced with decisions concerning the safety of endoscopic procedures in these patients. Based on expert opinion and on data from observational studies, we suggest algorithms for the approach to acute and elective procedures based on procedural risk and on risks for thromboembolic episodes. Udgivelsesdato: 2009-Apr-20

AB - Drugs that interfere with haemostasis are widely used for thromboembolic diseases and cardiovascular protection. Gastrointestinal bleeding is a well-known complication, and endoscopists are often faced with decisions concerning the safety of endoscopic procedures in these patients. Based on expert opinion and on data from observational studies, we suggest algorithms for the approach to acute and elective procedures based on procedural risk and on risks for thromboembolic episodes. Udgivelsesdato: 2009-Apr-20

M3 - Tidsskriftartikel

C2 - 19413934

SN - 0041-5782

VL - 171

SP - 1384

EP - 1386

JO - Ugeskrift for læger

JF - Ugeskrift for læger

IS - 17

ER -